Published in Eye (Lond) on January 01, 1992
Transpalpebral extrusion of solid silicone buckle. Oman J Ophthalmol (2009) 0.81
Risk factors for scleral buckle removal: a matched, case-control study. Trans Am Ophthalmol Soc (2008) 0.79
Transmuscular Migration of a Scleral Tunnel-Secured Encircling Silicone Band. Case Rep Ophthalmol (2016) 0.75
[Diplopia 10 years after scleral buckling surgery]. Ophthalmologe (2016) 0.75
Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology (1996) 2.36
Simple retinal detachments: identifying the at-risk case. Eye (Lond) (2002) 2.26
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye (Lond) (1997) 1.67
Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol (1987) 1.58
Pneumatic retinopexy in the treatment of primary rhegmatogenous retinal detachment. Eye (Lond) (1999) 1.47
The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) (1998) 1.43
Surgical removal of choroidal neovascular membranes after laser photocoagulation for diabetic maculopathy. Eye (Lond) (2001) 1.38
Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol (1996) 1.35
Silicone oil removal. I. The effect on the complications of silicone oil. Br J Ophthalmol (1987) 1.30
Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol (1996) 1.25
Systemic risk factors for idiopathic macular holes: a case-control study. Eye (Lond) (1998) 1.25
Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol (2000) 1.24
Macular microholes: pathogenesis and natural history. Br J Ophthalmol (2005) 1.22
Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery. Ophthalmology (1992) 1.13
Retinitis pigmentosa and retinal neovascularization. Ophthalmology (1986) 1.06
Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology (1993) 1.05
Vanishing retinal arterial aneurysms: a case report. Br J Ophthalmol (1992) 1.01
Corneal astigmatism following cataract extraction. Br J Ophthalmol (1986) 1.01
Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol (2005) 1.01
A prospective study of the effect of a unilateral macular hole on sensory and motor binocular function and recovery following successful surgery. Br J Ophthalmol (2004) 1.00
Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol (1993) 0.97
Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope. Br J Ophthalmol (1998) 0.94
Surgical treatment of full-thickness macular holes using autologous serum. Eye (Lond) (1996) 0.93
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93
Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol (2000) 0.93
Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology (1998) 0.92
Laser treatment of retinal angiomatosis. Eye (Lond) (1989) 0.89
Acute full-thickness macular hole after uncomplicated phacoemulsification cataract surgery. Am J Ophthalmol (2001) 0.88
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation. Br J Ophthalmol (1999) 0.88
Electroretinographic changes after vitrectomy and intraocular tamponade. Retina (1985) 0.87
Symmetry of disciform scars in bilateral age-related macular degeneration. Br J Ophthalmol (1991) 0.87
Giant retinal tear and retinal detachment with underlying retinitis pigmentosa and hearing loss. Eye (Lond) (1996) 0.87
The surgical management of uveal effusion syndrome. Eye (Lond) (1987) 0.86
Delayed suprachoroidal haemorrhage after glaucoma operations. Eye (Lond) (1989) 0.85
Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol (1997) 0.85
Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes. Br J Ophthalmol (1992) 0.84
Partial laser ablation of massive peripapillary subretinal neovascularization. Ophthalmology (1996) 0.83
Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol (2001) 0.82
Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers. Eye (Lond) (1990) 0.82
Juvenile coats disease associated with epiretinal membrane formation. Retina (1995) 0.81
Delayed fellow eye involvement in acute retinal necrosis syndrome. Am J Ophthalmol (1995) 0.80
Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation. Eye (Lond) (2005) 0.80
Intraocular pressure responses to systemic autonomic stimulation. Eye (Lond) (1989) 0.79
A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology (1999) 0.78
Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations. Eye (Lond) (2005) 0.78
Retinal detachment in patients with proliferative sickle cell retinopathy. Trans Ophthalmol Soc U K (1986) 0.78
Complete cryptophthalmos: case report with normal flash-VEP and ERG. J Pediatr Ophthalmol Strabismus (1990) 0.76
Oestrogens and macular holes: a postal questionnaire. Eye (Lond) (1994) 0.76
Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes. Ger J Ophthalmol (1995) 0.76
Intraocular penetration of tamoxifen. Ophthalmology (2000) 0.76
Use of a modified back-flush needle in diabetic vitrectomies. Br J Ophthalmol (1992) 0.75
Intraocular injection of depomedrone. Br J Ophthalmol (1986) 0.75
Post partum presentation of hypercalcaemic sarcoidosis. Postgrad Med J (1985) 0.75
Hypothalamic hypopituitarism in a patient with a basal encephalocoele--treatment with luteinizing hormone-releasing hormone. Postgrad Med J (1984) 0.75
Who should treat diabetic retinopathy? Eye (Lond) (1988) 0.75
Cases reported at the FAN club meeting, Bonn, November 1984. Case 3. Retinitis pigmentosa and retinal neovascularization. Int Ophthalmol (1985) 0.75
Indirect argon laser drainage of subretinal fluid. Eye (Lond) (1996) 0.75
Macular holes viewed objectively. Br J Ophthalmol (1997) 0.75
Detection of prednisolone in vitreous following systemic administration. Eye (Lond) (1998) 0.75
Practice patterns of pneumatic retinopexy in the United Kingdom. Br J Ophthalmol (2001) 0.75
Acquired peripheral retinal telangiectasia after retinal surgery. Retina (1994) 0.75
Subconjunctival injections of antibiotics are used increasingly at the conclusion of intraocular and extraocular procedures. Eye (Lond) (1989) 0.75
[Retinal vasculopathy associated with Berger's IgA nephropathy]. Klin Monbl Augenheilkd (2000) 0.75
Blurred vision. Br J Hosp Med (1985) 0.75
Electrophysiological responses after vitrectomy and intraocular tamponade. Trans Ophthalmol Soc U K (1985) 0.75
Intraocular lymphoma--a case report. Cytopathology (1993) 0.75
Isolated retinal telangiectatic masses. Trans Ophthalmol Soc U K (1986) 0.75
The removal of silicone oil from the anterior chamber in phakic eyes. Arch Ophthalmol (1987) 0.75